Literature DB >> 25815431

Opioid-induced hyperalgesia in community-dwelling adults with chronic pain.

W Michael Hooten1, Tim J Lamer, Channing Twyner.   

Abstract

The hyperalgesic effects of long-term opioid use in community-dwelling adults with chronic pain have not been widely reported. Therefore, the primary aim of this study was to determine the associations between opioid use and heat pain (HP) perception in a sample of community-dwelling adults with chronic pain. The study cohort involved 187 adults (85 opioid and 102 nonopioid) with chronic pain consecutively admitted to an outpatient interdisciplinary pain treatment program. Heat pain perception was assessed using a validated quantitative sensory test method of levels. An effect of opioid use was observed for nonstandardized (P = 0.004) and standardized (P = 0.005) values of HP 5-0.5 in which values of the opioid group were lower (more hyperalgesic) compared with those of the nonopioid group. HP 5-0.5 is a measure of the slope of the line connecting HP 0.5 (HP threshold) and HP 5 (intermediate measure of HP tolerance). In univariable (P = 0.019) and multiple variable (P = 0.003) linear regression analyses (adjusted for age, sex, body mass index, work status, pain diagnosis, pain severity, depression, and pain catastrophizing), opioid use was associated with lower (more hyperalgesic) nonstandardized values of HP 5-0.5. Similarly, in univariable (P = 0.004) and multiple variable (P = 0.011) linear regression analyses (adjusted for work status, pain diagnosis, pain severity, depression, and pain catastrophizing), opioid use was associated with lower standardized values of HP 5-0.5. In this sample of community-dwelling adults, these observations suggest that long-term opioid use was associated with hyperalgesia independent of other clinical factors known to influence HP perception.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25815431      PMCID: PMC4431900          DOI: 10.1097/j.pain.0000000000000170

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  54 in total

Review 1.  Use of percentiles and normal deviates to express nerve conduction and other test abnormalities.

Authors:  P J Dyck; P C O'Brien; W J Litchy; C M Harper; J R Daube; P J Dyck
Journal:  Muscle Nerve       Date:  2001-03       Impact factor: 3.217

2.  Perception of noxious and innocuous heat stimulation among healthy women and women with fibromyalgia: association with mood, somatic focus, and catastrophizing.

Authors:  Michael E Geisser; Kenneth L Casey; Christine B Brucksch; Christine M Ribbens; Brent B Appleton; Leslie J Crofford
Journal:  Pain       Date:  2003-04       Impact factor: 6.961

3.  Clinical outcomes of multidisciplinary pain rehabilitation among african american compared with caucasian patients with chronic pain.

Authors:  W Michael Hooten; Miranda Knight-Brown; Cynthia O Townsend; Heidi J Laures
Journal:  Pain Med       Date:  2012-09-19       Impact factor: 3.750

Review 4.  Do opioids induce hyperalgesia in humans? An evidence-based structured review.

Authors:  David A Fishbain; Brandly Cole; John E Lewis; Jinrun Gao; R Steele Rosomoff
Journal:  Pain Med       Date:  2009-07-06       Impact factor: 3.750

5.  On the utility of the West Haven-Yale Multidimensional Pain Inventory.

Authors:  I H Bernstein; M E Jaremko; B S Hinkley
Journal:  Spine (Phila Pa 1976)       Date:  1995-04-15       Impact factor: 3.468

6.  A population in pain: report from the Olmsted County health study.

Authors:  Emmeline A Watkins; Peter C Wollan; L Joseph Melton; Barbara P Yawn
Journal:  Pain Med       Date:  2008-03       Impact factor: 3.750

7.  The West Haven-Yale Multidimensional Pain Inventory (WHYMPI).

Authors:  R D Kerns; D C Turk; T E Rudy
Journal:  Pain       Date:  1985-12       Impact factor: 6.961

8.  Cool, warm, and heat-pain detection thresholds: testing methods and inferences about anatomic distribution of receptors.

Authors:  P J Dyck; I Zimmerman; D A Gillen; D Johnson; J L Karnes; P C O'Brien
Journal:  Neurology       Date:  1993-08       Impact factor: 9.910

9.  Sex differences in characteristics of smokers with chronic pain undergoing multidisciplinary pain rehabilitation.

Authors:  W Michael Hooten; Cynthia O Townsend; Barbara K Bruce; Yu Shi; David O Warner
Journal:  Pain Med       Date:  2009-09-01       Impact factor: 3.750

10.  Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal.

Authors:  Martin S Angst; Wolfgang Koppert; Ilka Pahl; David J Clark; Martin Schmelz
Journal:  Pain       Date:  2003-11       Impact factor: 6.961

View more
  14 in total

Review 1.  Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit.

Authors:  Adeleke D Adewumi; Christine E Staatz; Samantha A Hollingworth; Jason P Connor; Rosa Alati
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

2.  Medical Use of Long-term Extended-release Opioid Analgesics in Commercially Insured Adults in the United States.

Authors:  Jessica C Young; Michele Jonsson Funk; Nabarun Dasgupta
Journal:  Pain Med       Date:  2020-04-01       Impact factor: 3.750

3.  Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activation.

Authors:  Peter M Grace; Keith A Strand; Erika L Galer; Daniel J Urban; Xiaohui Wang; Michael V Baratta; Timothy J Fabisiak; Nathan D Anderson; Kejun Cheng; Lisa I Greene; Debra Berkelhammer; Yingning Zhang; Amanda L Ellis; Hang Hubert Yin; Serge Campeau; Kenner C Rice; Bryan L Roth; Steven F Maier; Linda R Watkins
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

Review 4.  Opioid-induced constipation: advances and clinical guidance.

Authors:  Alfred D Nelson; Michael Camilleri
Journal:  Ther Adv Chronic Dis       Date:  2016-01-25       Impact factor: 5.091

Review 5.  Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations.

Authors:  Caroline A Arout; Ellen Edens; Ismene L Petrakis; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2015-06       Impact factor: 5.749

6.  Prescription Medication Use Among Community-Based U.S. Adults With Chronic Low Back Pain: A Cross-Sectional Population Based Study.

Authors:  Anna Shmagel; Linh Ngo; Kristine Ensrud; Robert Foley
Journal:  J Pain       Date:  2018-04-17       Impact factor: 5.820

7.  Long-term Management of Low Back Pain with Opioids and Non-steroidal Anti-inflammatory Drugs in a Health System.

Authors:  Brian K Ahmedani; Edward L Peterson; Karen E Wells; Fady Henein; L Keoki Williams
Journal:  Am J Prev Med       Date:  2016-03-09       Impact factor: 5.043

8.  Preclinical Assessment of the Analgesic Pharmacology of NKTR-181 in Rodents.

Authors:  Caroline M Kopruszinski; Juliana Swiokla; Yeon Sun Lee; Edita Navratilova; Laurie VanderVeen; Miao Yang; Yi Liu; Takahiro Miyazaki; William K Schmidt; Jonathan Zalevsky; Frank Porreca
Journal:  Cell Mol Neurobiol       Date:  2020-02-27       Impact factor: 5.046

9.  GluN2B N-methyl-D-aspartate receptor and excitatory amino acid transporter 3 are upregulated in primary sensory neurons after 7 days of morphine administration in rats: implication for opiate-induced hyperalgesia.

Authors:  Kerui Gong; Aditi Bhargava; Luc Jasmin
Journal:  Pain       Date:  2016-01       Impact factor: 7.926

10.  Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study.

Authors:  Andrew Schrepf; Daniel E Harper; Steven E Harte; Heng Wang; Eric Ichesco; Johnson P Hampson; Jon-Kar Zubieta; Daniel J Clauw; Richard E Harris
Journal:  Pain       Date:  2016-10       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.